Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,061 | -11,573 | -24,873 | -20,093 | -15,535 |
| Depreciation Amortization | 12 | 13 | 14 | 7 | 1 |
| Accounts payable and accrued liabilities | 189 | 199 | 367 | -1 | 228 |
| Other Working Capital | -1,222 | -464 | 68 | 2,085 | 129 |
| Other Operating Activity | 2,720 | 861 | 1,186 | 768 | 1,459 |
| Operating Cash Flow | $-18,362 | $-10,964 | $-23,238 | $-17,234 | $-13,718 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 5,930 | 1,000 | 26,676 | 40,971 | 26,845 |
| PPE Investments | -7 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -3,594 | -6,380 | -1,315 | -25,863 | -66,358 |
| Investing Cash Flow | $2,329 | $-5,380 | $25,361 | $15,108 | $-39,513 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -13 | -13 | 31 | 11 | 62 |
| Common Stock Issued | 19,329 | 18,884 | 2,936 | 1 | 49,026 |
| Financing Cash Flow | $19,316 | $18,871 | $2,967 | $12 | $49,088 |
| Beginning Cash Position | 11,433 | 8,906 | 3,816 | 5,930 | 10,073 |
| End Cash Position | 14,716 | 11,433 | 8,906 | 3,816 | 5,930 |
| Net Cash Flow | $3,283 | $2,527 | $5,090 | $-2,114 | $-4,143 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,362 | -10,964 | -23,238 | -17,234 | -13,718 |
| Capital Expenditure | -7 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -18,369 | -10,964 | -23,238 | -17,234 | -13,718 |